{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:43:02Z","timestamp":1789576982329,"version":"build-2803163510"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of this study was to investigate the effect of arterial hypertension (AH) and of obstructive sleep apnea (OSA) on cognitive course in the neurocognitive disorder (NCD) cohort RIFADE which enrolled patients with NCD due to Alzheimer\u2019s disease (AD), vascular NCD (vNCD), and mixed NCD (AD\u2009+\u2009vNCD\u2009=\u2009mNCD). Multiple risk factors (RF), including AH and OSA, that contribute to the development of various kinds of dementia have been identified in previous studies. Studies that observed AH lacked investigation of long-term effects and did not isolate it from other RF. Studies involving OSA as a risk factor did not include participants with all stages of NCD. 126 subjects were screened for AH and OSA. Repeated cognitive measurements were performed with the DemTect as primary outcome and the clock drawing test as secondary outcome measure. 90 patients had AH (71.4%) and 40 patients had OSA (31.7%). RF-status had a significant effect on cognitive outcome in models with RF as single factors (AH p\u2009=\u20090.027, OSA p\u2009&lt;\u20090.001), a 2-factor analysis with AH \u00d7 OSA (AH as main factor p\u2009=\u20090.027) as well as a model including the 3 factors AH \u00d7 OSA \u00d7 diagnosis (p\u2009=\u20090.038). Similarly, a 3-factor model was significant for the clock-drawing test, whereas single factor-models remained insignificant. AH and OSA appear to be risk factors in common NCD and cognitive decline can be mitigated by treatment of these RF.<\/jats:p>","DOI":"10.1038\/s41598-023-33701-2","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:02:17Z","timestamp":1683702137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of hypertension and obstructive sleep apnea counteracts cognitive decline in common neurocognitive disorders in diagnosis-related patterns"],"prefix":"10.1038","volume":"13","author":[{"given":"Milenko","family":"Kujovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"J\u00e4nner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"10248","key":"33701_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet 396(10248), 413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6 (2020).","journal-title":"The Lancet"},{"issue":"1","key":"33701_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song, C. et al. Immunotherapy for Alzheimer\u2019s disease: Targeting \u03b2-amyloid and beyond. Transl. Neurodegener. 11(1), 18. https:\/\/doi.org\/10.1186\/s40035-022-00292-3 (2022).","journal-title":"Transl. Neurodegener."},{"key":"33701_CR3","doi-asserted-by":"publisher","first-page":"120294","DOI":"10.1016\/j.jns.2022.120294","volume":"438","author":"JJ Luo","year":"2022","unstructured":"Luo, J. J., Wallace, W. & Kusiak, J. W. A tough trek in the development of an anti-amyloid therapy for Alzheimer\u2019s disease: Do we see hope in the distance?. J. Neurol. Sci. 438, 120294. https:\/\/doi.org\/10.1016\/j.jns.2022.120294 (2022).","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"33701_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JAD-220046","volume":"87","author":"E Lacorte","year":"2022","unstructured":"Lacorte, E. et al. Safety and efficacy of monoclonal antibodies for alzheimer\u2019s disease: A systematic review and meta-analysis of published and unpublished clinical trials. J. Alzheimer. Dis. 87(1), 101\u2013129. https:\/\/doi.org\/10.3233\/JAD-220046 (2022).","journal-title":"J. Alzheimer. Dis."},{"key":"33701_CR5","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.nbd.2019.104707","volume":"134","author":"A Bittar","year":"2020","unstructured":"Bittar, A., Bhatt, N. & Kayed, R. Advances and considerations in AD tau-targeted immunotherapy. Neurobiol. Dis. 134, 104707. https:\/\/doi.org\/10.1016\/j.nbd.2019.104707 (2020).","journal-title":"Neurobiol. Dis."},{"key":"33701_CR6","doi-asserted-by":"publisher","first-page":"108104","DOI":"10.1016\/j.neuropharm.2020.108104","volume":"175","author":"LA Sandusky-Beltran","year":"2020","unstructured":"Sandusky-Beltran, L. A. & Sigurdsson, E. M. Tau immunotherapies: Lessons learned, current status and future considerations. Neuropharmacology 175, 108104. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108104 (2020).","journal-title":"Neuropharmacology"},{"issue":"5","key":"33701_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1161\/STROKEAHA.115.012608","volume":"47","author":"MP Pase","year":"2016","unstructured":"Pase, M. P. et al. Association of ideal cardiovascular health with vascular brain injury and incident dementia. Stroke 47(5), 1201\u20131206 (2016).","journal-title":"Stroke"},{"issue":"10","key":"33701_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","volume":"17","author":"Z Ungvari","year":"2021","unstructured":"Ungvari, Z. et al. Hypertension-induced cognitive impairment: From pathophysiology to public health. Nat. Rev. Nephrol. 17(10), 639\u2013654. https:\/\/doi.org\/10.1038\/s41581-021-00430-6 (2021).","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"33701_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/CIRCRESAHA.118.313260","volume":"124","author":"C Iadecola","year":"2019","unstructured":"Iadecola, C. & Gottesman, R. F. Neurovascular and cognitive dysfunction in hypertension. Circ. Res. 124(7), 1025\u20131044. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313260 (2019).","journal-title":"Circ. Res."},{"issue":"2","key":"33701_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3233\/jad-210252","volume":"82","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Systolic blood pressure and cognition in the elderly: The northern manhattan study. J. Alzheimer. Dis. 82(2), 689\u2013699. https:\/\/doi.org\/10.3233\/jad-210252 (2021).","journal-title":"J. Alzheimer. Dis."},{"issue":"1","key":"33701_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12916-021-02165-4","volume":"19","author":"Y Ma","year":"2021","unstructured":"Ma, Y. et al. Different hypertension thresholds and cognitive decline: A pooled analysis of three ageing cohorts. BMC Med. 19(1), 287. https:\/\/doi.org\/10.1186\/s12916-021-02165-4 (2021).","journal-title":"BMC Med."},{"issue":"2","key":"33701_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/HYPERTENSIONAHA.120.16080","volume":"77","author":"ST de Menezes","year":"2021","unstructured":"de Menezes, S. T. et al. Hypertension, prehypertension, and hypertension control: Association with decline in cognitive performance in the ELSA-Brasil Cohort. Hypertens. (Dallas Tex: 1979) 77(2), 672\u2013681. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16080 (2021).","journal-title":"Hypertens. (Dallas Tex: 1979)"},{"issue":"4","key":"33701_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.31083\/j.rcm2204148","volume":"22","author":"S Mahinrad","year":"2021","unstructured":"Mahinrad, S., Sorond, F. A. & Gorelick, P. B. Hypertension and cognitive dysfunction: A review of mechanisms, life-course observational studies and clinical trial results. Rev. Cardiovasc. Med. 22(4), 1429\u20131449. https:\/\/doi.org\/10.31083\/j.rcm2204148 (2021).","journal-title":"Rev. Cardiovasc. Med."},{"issue":"11","key":"33701_CR14","doi-asserted-by":"publisher","first-page":"e038971","DOI":"10.1136\/bmjopen-2020-038971","volume":"10","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Treatment of hypertension reduces cognitive decline in older adults: A systematic review and meta-analysis. BMJ Open 10(11), e038971. https:\/\/doi.org\/10.1136\/bmjopen-2020-038971 (2020).","journal-title":"BMJ Open"},{"issue":"7","key":"33701_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/gps.2572","volume":"26","author":"SI Sharp","year":"2011","unstructured":"Sharp, S. I., Aarsland, D., Day, S., S\u00f8nnesyn, H. & Ballard, C. Hypertension is a potential risk factor for vascular dementia: Systematic review. Int. J. Geriatr. Psychiatry 26(7), 661\u2013669. https:\/\/doi.org\/10.1002\/gps.2572 (2011).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"33701_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3233\/JAD-2010-101110","volume":"22","author":"F Bermejo-Pareja","year":"2010","unstructured":"Bermejo-Pareja, F. et al. Risk of incident dementia in drug-untreated arterial hypertension: A population-based study. J. Alzheim. Dis. 22(3), 949\u2013958. https:\/\/doi.org\/10.3233\/JAD-2010-101110 (2010).","journal-title":"J. Alzheim. Dis."},{"issue":"9","key":"33701_CR17","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/jgs.13627","volume":"63","author":"W Wharton","year":"2015","unstructured":"Wharton, W. et al. Modulation of renin-angiotensin system may slow conversion from mild cognitive impairment to alzheimer\u2019s disease. J. Am. Geriatr. Soc. 63(9), 1749\u20131756. https:\/\/doi.org\/10.1111\/jgs.13627 (2015).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"33701_CR18","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/jgs.12415","volume":"61","author":"ME Soto","year":"2013","unstructured":"Soto, M. E. et al. Angiotensin-converting enzyme inhibitors and Alzheimer\u2019s disease progression in older adults: Results from the R\u00e9seau sur la Maladie d\u2019s Alzheimer Fran\u00e7ais cohort. J. Am. Geriatr. Soc. 61(9), 1482\u20131488. https:\/\/doi.org\/10.1111\/jgs.12415 (2013).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"33701_CR19","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1002\/hsr2.228","volume":"4","author":"B Linssen","year":"2021","unstructured":"Linssen, B., Bergman, E., Klarenbeek, P. & Hoff, E. Prevalence of obstructive sleep apnea at an outpatient memory clinic. Health Sci. Rep. 4(1), e228. https:\/\/doi.org\/10.1002\/hsr2.228 (2021).","journal-title":"Health Sci. Rep."},{"issue":"5","key":"33701_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.sleep.2009.10.005","volume":"11","author":"S Tufik","year":"2010","unstructured":"Tufik, S., Santos-Silva, R., Taddei, J. A. & Bittencourt, L. R. A. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med. 11(5), 441\u2013446. https:\/\/doi.org\/10.1016\/j.sleep.2009.10.005 (2010).","journal-title":"Sleep Med."},{"key":"33701_CR21","doi-asserted-by":"publisher","first-page":"105054","DOI":"10.1016\/j.nbd.2020.105054","volume":"145","author":"AE Mullins","year":"2020","unstructured":"Mullins, A. E. et al. Obstructive Sleep apnea and its treatment in aging: Effects on alzheimer\u2019s disease biomarkers, cognition, brain structure and neurophysiology. Neurobiol. Dis. 145, 105054. https:\/\/doi.org\/10.1016\/j.nbd.2020.105054 (2020).","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"33701_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0022034519885644","volume":"99","author":"GJ Lavigne","year":"2020","unstructured":"Lavigne, G. J. et al. Critical issues in dental and medical management of obstructive sleep apnea. J. Dent. Res. 99(1), 26\u201335. https:\/\/doi.org\/10.1177\/0022034519885644 (2020).","journal-title":"J. Dent. Res."},{"key":"33701_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ebiom.2016.03.020","volume":"7","author":"I Rosenzweig","year":"2016","unstructured":"Rosenzweig, I. et al. Changes in neurocognitive architecture in patients with obstructive sleep apnea treated with continuous positive airway pressure. EBioMedicine 7, 221\u2013229. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.020 (2016).","journal-title":"EBioMedicine"},{"issue":"4","key":"33701_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/09540260500104508","volume":"17","author":"B El-Ad","year":"2005","unstructured":"El-Ad, B. & Lavie, P. Effect of sleep apnea on cognition and mood. Int. Rev. Psychiatry (Abingdon, Engl.) 17(4), 277\u2013282. https:\/\/doi.org\/10.1080\/09540260500104508 (2005).","journal-title":"Int. Rev. Psychiatry (Abingdon, Engl.)"},{"key":"33701_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/15500594221090067","author":"RR Gilley","year":"2022","unstructured":"Gilley, R. R. The role of sleep in cognitive function: The value of a good night\u2019s rest. Clin. EEG Neurosci. https:\/\/doi.org\/10.1177\/15500594221090067 (2022).","journal-title":"Clin. EEG Neurosci."},{"issue":"5","key":"33701_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/13803395.2021.1944609","volume":"43","author":"L Macchitella","year":"2021","unstructured":"Macchitella, L. et al. Neuropsychological and socio-cognitive deficits in patients with obstructive sleep apnea. J. Clin. Exp. Neuropsychol. 43(5), 514\u2013533. https:\/\/doi.org\/10.1080\/13803395.2021.1944609 (2021).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"33701_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/brainsci10060325","volume":"10","author":"P Angelelli","year":"2020","unstructured":"Angelelli, P. et al. The neuropsychological profile of attention deficits of patients with obstructive sleep apnea: An update on the daytime attentional impairment. Brain Sci. 10, 6. https:\/\/doi.org\/10.3390\/brainsci10060325 (2020).","journal-title":"Brain Sci."},{"issue":"9","key":"33701_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.5665\/sleep.2950","volume":"36","author":"M Olaithe","year":"2013","unstructured":"Olaithe, M. & Bucks, R. S. Executive dysfunction in OSA before and after treatment: A meta-analysis. Sleep 36(9), 1297\u20131305. https:\/\/doi.org\/10.5665\/sleep.2950 (2013).","journal-title":"Sleep"},{"key":"33701_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.smrv.2017.03.005","volume":"38","author":"M Olaithe","year":"2018","unstructured":"Olaithe, M., Bucks, R. S., Hillman, D. R. & Eastwood, P. R. Cognitive deficits in obstructive sleep apnea: Insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation. Sleep Med. Rev. 38, 39\u201349. https:\/\/doi.org\/10.1016\/j.smrv.2017.03.005 (2018).","journal-title":"Sleep Med. Rev."},{"key":"33701_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/sleep\/zsy199","volume":"42","author":"JE Owen","year":"2019","unstructured":"Owen, J. E., Benediktsd\u00d3ttir, B., Gislason, T. & Robinson, S. R. Neuropathological investigation of cell layer thickness and myelination in the hippocampus of people with obstructive sleep apnea. Sleep 42, 1. https:\/\/doi.org\/10.1093\/sleep\/zsy199 (2019).","journal-title":"Sleep"},{"issue":"7","key":"33701_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11910-021-01123-0","volume":"21","author":"G Seda","year":"2021","unstructured":"Seda, G., Matwiyoff, G. & Parrish, J. S. Effects of obstructive sleep apnea and CPAP on cognitive function. Curr. Neurol. Neurosci. Rep. 21(7), 32. https:\/\/doi.org\/10.1007\/s11910-021-01123-0 (2021).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"3","key":"33701_CR32","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/jgs.15758","volume":"67","author":"KC Richards","year":"2019","unstructured":"Richards, K. C. et al. Cpap adherence may slow 1-year cognitive decline in older adults with mild cognitive impairment and apnea. J. Am. Geriatr. Soc. 67(3), 558\u2013564. https:\/\/doi.org\/10.1111\/jgs.15758 (2019).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"33701_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/NNR.0000000000000420","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. One year of continuous positive airway pressure adherence improves cognition in older adults with mild apnea and mild cognitive impairment. Nurs. Res. 69(2), 157\u2013164. https:\/\/doi.org\/10.1097\/NNR.0000000000000420 (2020).","journal-title":"Nurs. Res."},{"issue":"19","key":"33701_CR34","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","volume":"342","author":"PE Peppard","year":"2000","unstructured":"Peppard, P. E., Young, T., Palta, M. & Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 342(19), 1378\u20131384. https:\/\/doi.org\/10.1056\/NEJM200005113421901 (2000).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"33701_CR35","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.7189\/jogh.08.010405","volume":"8","author":"H Hou","year":"2018","unstructured":"Hou, H. et al. Association of obstructive sleep apnea with hypertension: A systematic review and meta-analysis. J. Glob. Health 8(1), 10405. https:\/\/doi.org\/10.7189\/jogh.08.010405 (2018).","journal-title":"J. Glob. Health"},{"issue":"2","key":"33701_CR36","doi-asserted-by":"publisher","first-page":"e0192671","DOI":"10.1371\/journal.pone.0192671","volume":"13","author":"RL Tveit","year":"2018","unstructured":"Tveit, R. L., Lehmann, S. & Bjorvatn, B. Prevalence of several somatic diseases depends on the presence and severity of obstructive sleep apnea. PLoS ONE 13(2), e0192671. https:\/\/doi.org\/10.1371\/journal.pone.0192671 (2018).","journal-title":"PLoS ONE"},{"issue":"4","key":"33701_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5664\/jcsm.27538","volume":"5","author":"JR Cooke","year":"2009","unstructured":"Cooke, J. R. et al. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer\u2019s disease and obstructive sleep apnea: A preliminary study. J. Clin. Sleep Med. 5(4), 305\u2013309 (2009).","journal-title":"J. Clin. Sleep Med."},{"issue":"2","key":"33701_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5664\/jcsm.5478","volume":"12","author":"JM Dzierzewski","year":"2016","unstructured":"Dzierzewski, J. M., Wallace, D. M. & Wohlgemuth, W. K. Adherence to continuous positive airway pressure in existing users: Self-efficacy enhances the association between continuous positive airway pressure and adherence. J. Clin. Sleep Med. 12(2), 169\u2013176. https:\/\/doi.org\/10.5664\/jcsm.5478 (2016).","journal-title":"J. Clin. Sleep Med."},{"key":"33701_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-022-01485-7","author":"W Duan","year":"2022","unstructured":"Duan, W. et al. Distinct functional brain abnormalities in insomnia disorder and obstructive sleep apnea. Eur. Arch. Psychiatry Clin. Neurosci. https:\/\/doi.org\/10.1007\/s00406-022-01485-7 (2022).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"10","key":"33701_CR40","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/jnr.24858","volume":"99","author":"M Salsone","year":"2021","unstructured":"Salsone, M. et al. Microstructural changes in normal-appearing white matter in male sleep apnea patients are reversible after treatment: A pilot study. J. Neurosci. Res. 99(10), 2646\u20132656. https:\/\/doi.org\/10.1002\/jnr.24858 (2021).","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"33701_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hbm.23038","volume":"37","author":"H Kim","year":"2016","unstructured":"Kim, H. et al. Effects of long-term treatment on brain volume in patients with obstructive sleep apnea syndrome. Hum. Brain Mapp. 37(1), 395\u2013409. https:\/\/doi.org\/10.1002\/hbm.23038 (2016).","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"33701_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.neuroimage.2010.09.065","volume":"54","author":"F Torelli","year":"2011","unstructured":"Torelli, F. et al. Cognitive profile and brain morphological changes in obstructive sleep apnea. Neuroimage 54(2), 787\u2013793. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.09.065 (2011).","journal-title":"Neuroimage"},{"issue":"10","key":"33701_CR43","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1007\/s00415-022-11182-z","volume":"269","author":"M Fernandes","year":"2022","unstructured":"Fernandes, M. et al. 18f-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment. J. Neurol. 269(10), 5356\u20135367. https:\/\/doi.org\/10.1007\/s00415-022-11182-z (2022).","journal-title":"J. Neurol."},{"issue":"5","key":"33701_CR44","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1378\/chest.15-0171","volume":"148","author":"M Dalmases","year":"2015","unstructured":"Dalmases, M. et al. Effect of CPAP on cognition, brain function, and structure among elderly patients with OSA: A randomized pilot study. Chest 148(5), 1214\u20131223. https:\/\/doi.org\/10.1378\/chest.15-0171 (2015).","journal-title":"Chest"},{"issue":"12","key":"33701_CR45","doi-asserted-by":"publisher","first-page":"e01889","DOI":"10.1002\/brb3.1889","volume":"10","author":"Y-T Chang","year":"2020","unstructured":"Chang, Y.-T. et al. Functional connectivity in default mode network correlates with severity of hypoxemia in obstructive sleep apnea. Brain Behav. 10(12), e01889. https:\/\/doi.org\/10.1002\/brb3.1889 (2020).","journal-title":"Brain Behav."},{"issue":"12","key":"33701_CR46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1136\/jnnp-2013-307544","volume":"85","author":"A-C Troussi\u00e8re","year":"2014","unstructured":"Troussi\u00e8re, A.-C. et al. Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatry 85(12), 1405\u20131408. https:\/\/doi.org\/10.1136\/jnnp-2013-307544 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"19","key":"33701_CR47","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1212\/WNL.0000000000001566","volume":"84","author":"RS Osorio","year":"2015","unstructured":"Osorio, R. S. et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 84(19), 1964\u20131971. https:\/\/doi.org\/10.1212\/WNL.0000000000001566 (2015).","journal-title":"Neurology"},{"issue":"4","key":"33701_CR48","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s11325-021-02320-4","volume":"25","author":"C Liguori","year":"2021","unstructured":"Liguori, C. et al. Obstructive sleep apnea syndrome and Alzheimer&apos;s disease pathology: May continuous positive airway pressure treatment delay cognitive deterioration?. Sleep Breath. 25(4), 2135\u20132139. https:\/\/doi.org\/10.1007\/s11325-021-02320-4 (2021).","journal-title":"Sleep Breath."},{"key":"33701_CR49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2016.00078","volume":"8","author":"F Emamian","year":"2016","unstructured":"Emamian, F. et al. The association between obstructive sleep apnea and alzheimer\u2019s disease: A meta-analysis perspective. Front. Aging Neurosci. 8, 78. https:\/\/doi.org\/10.3389\/fnagi.2016.00078 (2016).","journal-title":"Front. Aging Neurosci."},{"key":"33701_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-022-01516-3","author":"B Baumann","year":"2022","unstructured":"Baumann, B., Lipka, T., J\u00e4nner, M. & Kujovic, M. The Neurocognitive Disorder Cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup. Eur. Arch. Psychiatry Clin. Neurosci. https:\/\/doi.org\/10.1007\/s00406-022-01516-3 (2022).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"33701_CR51","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia, M. J. International classification of sleep disorders-third edition: Highlights and modifications. Chest 146(5), 1387\u20131394. https:\/\/doi.org\/10.1378\/chest.14-0970 (2014).","journal-title":"Chest"},{"key":"33701_CR52","doi-asserted-by":"publisher","first-page":"153331752094980","DOI":"10.1177\/1533317520949805","volume":"35","author":"GS Aycicek","year":"2020","unstructured":"Aycicek, G. S. et al. A reliable tool for assessing MCI and dementia: Validation study of DemTect for Turkish population. Am. J. Alzheim. Dis. Other Demen. 35, 1533317520949805. https:\/\/doi.org\/10.1177\/1533317520949805 (2020).","journal-title":"Am. J. Alzheim. Dis. Other Demen."},{"issue":"1","key":"33701_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12931-019-1217-5","volume":"20","author":"SM von Siemens","year":"2019","unstructured":"von Siemens, S. M. et al. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: Results from the COSYCONET cohort. Respir. Res. 20(1), 257. https:\/\/doi.org\/10.1186\/s12931-019-1217-5 (2019).","journal-title":"Respir. Res."},{"issue":"6","key":"33701_CR54","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/1099-1166(200006)15:6%3C548::aid-gps242%3E3.0.co;2-u","volume":"15","author":"KI Shulman","year":"2000","unstructured":"Shulman, K. I. Clock-drawing: Is it the ideal cognitive screening test?. Int. J. Geriatr. Psychiatry 15(6), 548\u2013561. https:\/\/doi.org\/10.1002\/1099-1166(200006)15:6%3C548::aid-gps242%3E3.0.co;2-u (2000).\u00a0","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"33701_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/0891988714554709","volume":"28","author":"S Amodeo","year":"2015","unstructured":"Amodeo, S., Mainland, B. J., Herrmann, N. & Shulman, K. I. The times they are a-changin\u2019: Clock drawing and prediction of dementia. J. Geriatr. Psychiatry Neurol. 28(2), 145\u2013155. https:\/\/doi.org\/10.1177\/0891988714554709 (2015).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"12","key":"33701_CR56","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1111\/jan.13810","volume":"74","author":"J Park","year":"2018","unstructured":"Park, J., Jeong, E. & Seomun, G. The clock drawing test: A systematic review and meta-analysis of diagnostic accuracy. J. Adv. Nurs. 74(12), 2742\u20132754. https:\/\/doi.org\/10.1111\/jan.13810 (2018).","journal-title":"J. Adv. Nurs."},{"issue":"6","key":"33701_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1590\/0004-282X20140055","volume":"72","author":"P Caramelli","year":"2014","unstructured":"Caramelli, P. et al. Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: A 24-week, randomized, placebo-controlled exploratory trial (the REMIX study). Arq. Neuropsiquiatr. 72(6), 411\u2013417. https:\/\/doi.org\/10.1590\/0004-282X20140055 (2014).","journal-title":"Arq. Neuropsiquiatr."},{"issue":"6","key":"33701_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/gps.1312","volume":"20","author":"L Rozzini","year":"2005","unstructured":"Rozzini, L. et al. Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. Int. J. Geriatr. Psychiatry 20(6), 547\u2013551. https:\/\/doi.org\/10.1002\/gps.1312 (2005).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"4","key":"33701_CR59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/gps.2735","volume":"27","author":"S Kennelly","year":"2012","unstructured":"Kennelly, S. et al. Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer\u2019s patients\u2014an open-label trial. Int. J. Geriatr. Psychiatry 27(4), 415\u2013422. https:\/\/doi.org\/10.1002\/gps.2735 (2012).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"11","key":"33701_CR60","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1212\/01.WNL.0000129258.93137.4B","volume":"62","author":"LE Hebert","year":"2004","unstructured":"Hebert, L. E. et al. Blood pressure and late-life cognitive function change: A biracial longitudinal population study. Neurology 62(11), 2021\u20132024. https:\/\/doi.org\/10.1212\/01.WNL.0000129258.93137.4B (2004).","journal-title":"Neurology"},{"issue":"7","key":"33701_CR61","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1532-5415.2000.tb04752.x","volume":"48","author":"A Di-Carlo","year":"2000","unstructured":"Di-Carlo, A. et al. Cognitive impairment without dementia in older people: Prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J. Am. Geriatr. Soc. 48(7), 775\u2013782. https:\/\/doi.org\/10.1111\/j.1532-5415.2000.tb04752.x (2000).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"11","key":"33701_CR62","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/oxfordjournals.aje.a116033","volume":"134","author":"PA Scherr","year":"1991","unstructured":"Scherr, P. A., Hebert, L. E., Smith, L. A. & Evans, D. A. Relation of blood pressure to cognitive function in the elderly. Am. J. Epidemiol. 134(11), 1303\u20131315. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116033 (1991).","journal-title":"Am. J. Epidemiol."},{"issue":"12","key":"33701_CR63","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41440-020-0499-9","volume":"43","author":"M Kabayama","year":"2020","unstructured":"Kabayama, M. et al. The association of blood pressure with physical frailty and cognitive function in community-dwelling septuagenarians, octogenarians, and nonagenarians: The SONIC study. Hypertens. Res. 43(12), 1421\u20131429. https:\/\/doi.org\/10.1038\/s41440-020-0499-9 (2020).","journal-title":"Hypertens. Res."},{"issue":"6","key":"33701_CR64","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/HJH.0000000000002013","volume":"37","author":"L Rouch","year":"2019","unstructured":"Rouch, L. et al. Blood pressure and cognitive performances in middle-aged adults: The Aging, Health and Work longitudinal study. J. Hypertens. 37(6), 1244\u20131253. https:\/\/doi.org\/10.1097\/HJH.0000000000002013 (2019).","journal-title":"J. Hypertens."},{"issue":"5","key":"33701_CR65","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/jgs.17583","volume":"70","author":"SA Gaussoin","year":"2022","unstructured":"Gaussoin, S. A. et al. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study. J. Am. Geriatr. Soc. 70(5), 1384\u20131393. https:\/\/doi.org\/10.1111\/jgs.17583 (2022).","journal-title":"J. Am. Geriatr. Soc."},{"key":"33701_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fnagi.2020.00257","volume":"12","author":"K Hestad","year":"2020","unstructured":"Hestad, K., Engedal, K., Horndalsveen, P. & Strand, B. H. Blood pressure in different dementia disorders, mild cognitive impairment, and subjective cognitive decline. Front. Aging Neurosci. 12, 257. https:\/\/doi.org\/10.3389\/fnagi.2020.00257 (2020).","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"33701_CR67","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2174\/1386207323666201211101720","volume":"22","author":"R Rahimi","year":"2021","unstructured":"Rahimi, R. et al. Effect of antihypertensive drugs on cognition and behavioral symptoms of patients with alzheimer\u2019s disease: A meta-analysis. Curr. Pharm. Biotechnol. 22(11), 1511\u20131519. https:\/\/doi.org\/10.2174\/1386207323666201211101720 (2021).","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"14","key":"33701_CR68","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.2017.3090","volume":"317","author":"RF Gottesman","year":"2017","unstructured":"Gottesman, R. F. et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA 317(14), 1443\u20131450. https:\/\/doi.org\/10.1001\/jama.2017.3090 (2017).","journal-title":"JAMA"},{"issue":"10","key":"33701_CR69","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/01.RES.0000148637.85595.c5","volume":"95","author":"K Kazama","year":"2004","unstructured":"Kazama, K. et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ. Res. 95(10), 1019\u20131026. https:\/\/doi.org\/10.1161\/01.RES.0000148637.85595.c5 (2004).","journal-title":"Circ. Res."},{"issue":"5","key":"33701_CR70","doi-asserted-by":"publisher","first-page":"H1890","DOI":"10.1152\/ajpheart.00464.2003","volume":"285","author":"K Kazama","year":"2003","unstructured":"Kazama, K., Wang, G., Frys, K., Anrather, J. J. & Iadecola, C. Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. Am. J. Physiol. Heart Circul. Physiol. 285(5), H1890\u2013H1899. https:\/\/doi.org\/10.1152\/ajpheart.00464.2003 (2003).","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"issue":"2","key":"33701_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/01.ATV.0000253885.41509.25","volume":"27","author":"H Girouard","year":"2007","unstructured":"Girouard, H., Park, L., Anrather, J. J., Zhou, P. & Iadecola, C. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27(2), 303\u2013309. https:\/\/doi.org\/10.1161\/01.ATV.0000253885.41509.25 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"33701_CR72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.109.133249","volume":"54","author":"C Capone","year":"2009","unstructured":"Capone, C., Anrather, J. J., Milner, T. A. & Iadecola, C. Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex. Hypertens. (Dallas, Tex: 1979) 54(2), 302\u2013307. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.133249 (2009).","journal-title":"Hypertens. (Dallas, Tex: 1979)"},{"issue":"4","key":"33701_CR73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.109.145813","volume":"55","author":"C Capone","year":"2010","unstructured":"Capone, C., Faraco, G., Anrather, J. J., Zhou, P. & Iadecola, C. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertens. (Dallas, Tex: 1979) 55(4), 911\u2013917. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.145813 (2010).","journal-title":"Hypertens. (Dallas, Tex: 1979)"},{"issue":"1","key":"33701_CR74","doi-asserted-by":"publisher","first-page":"H397","DOI":"10.1152\/ajpheart.00679.2010","volume":"300","author":"C Capone","year":"2011","unstructured":"Capone, C. et al. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am. J. Physiol. Heart Circul. Physiol. 300(1), H397-407. https:\/\/doi.org\/10.1152\/ajpheart.00679.2010 (2011).","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"issue":"12","key":"33701_CR75","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1172\/jci86950","volume":"126","author":"G Faraco","year":"2016","unstructured":"Faraco, G. et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J. Clin. Investig. 126(12), 4674\u20134689. https:\/\/doi.org\/10.1172\/jci86950 (2016).","journal-title":"J. Clin. Investig."},{"issue":"4","key":"33701_CR76","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3233\/JAD-191339","volume":"76","author":"D Mohan","year":"2020","unstructured":"Mohan, D. et al. Link between dietary sodium intake, cognitive function, and dementia risk in middle-aged and older adults: A systematic review. J. Alzheim. Dis. 76(4), 1347\u20131373. https:\/\/doi.org\/10.3233\/JAD-191339 (2020).","journal-title":"J. Alzheim. Dis."},{"key":"33701_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-022-00710-z","author":"NX Wang","year":"2022","unstructured":"Wang, N. X. et al. The World Hypertension League Science of Salt: A regularly updated systematic review of salt and health outcomes studies (Sept 2019 to Dec 2020). J. Hum. Hypertens. https:\/\/doi.org\/10.1038\/s41371-022-00710-z (2022).","journal-title":"J. Hum. Hypertens."},{"issue":"8","key":"33701_CR78","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/jch.13937","volume":"22","author":"DY Tekle","year":"2020","unstructured":"Tekle, D. Y. et al. Monitoring and implementation of salt reduction initiatives in Africa: A systematic review. J. Clin. Hypertens. (Greenwich Conn.) 22(8), 1355\u20131370. https:\/\/doi.org\/10.1111\/jch.13937 (2020).","journal-title":"J. Clin. Hypertens. (Greenwich Conn.)"},{"issue":"2","key":"33701_CR79","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.numecd.2018.11.010","volume":"29","author":"FP Cappuccio","year":"2018","unstructured":"Cappuccio, F. P., Beer, M. & Strazzullo, P. Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement from the European Salt Action Network. Nutr. Metabol. Cardiovasc. Dis. 29(2), 107\u2013114. https:\/\/doi.org\/10.1016\/j.numecd.2018.11.010 (2018).","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"issue":"6","key":"33701_CR80","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacc.2019.11.055","volume":"75","author":"FJ He","year":"2020","unstructured":"He, F. J., Tan, M., Ma, Y. Y. & MacGregor, G. A. Salt reduction to prevent hypertension and cardiovascular disease: Jacc state-of-the-art review. J. Am. Coll. Cardiol. 75(6), 632\u2013647. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.055 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33701_CR81","doi-asserted-by":"publisher","first-page":"e070686","DOI":"10.1136\/bmj-2022-070686","volume":"377","author":"HE Burt","year":"2022","unstructured":"Burt, H. E., Brown, M. K., He, F. J. & MacGregor, G. A. Salt: The forgotten foe in UK public health policy. BMJ (Clin. Res. Ed.) 377, e070686. https:\/\/doi.org\/10.1136\/bmj-2022-070686 (2022).","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"5","key":"33701_CR82","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41440-022-00888-2","volume":"45","author":"T Tsuchihashi","year":"2022","unstructured":"Tsuchihashi, T. Dietary salt intake in Japan\u2014past, present, and future. Hypertens. Res. 45(5), 748\u2013757. https:\/\/doi.org\/10.1038\/s41440-022-00888-2 (2022).","journal-title":"Hypertens. Res."},{"issue":"7780","key":"33701_CR83","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-019-1688-z","volume":"574","author":"G Faraco","year":"2019","unstructured":"Faraco, G. et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature 574(7780), 686\u2013690. https:\/\/doi.org\/10.1038\/s41586-019-1688-z (2019).","journal-title":"Nature"},{"issue":"3","key":"33701_CR84","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.106.076190","volume":"51","author":"S Kapa","year":"2008","unstructured":"Kapa, S., Sert-Kuniyoshi, F. H. & Somers, V. K. Sleep apnea and hypertension: Interactions and implications for management. Hypertension (Dallas, Tex: 1979) 51(3), 605\u2013608. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.106.076190 (2008).","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"33701_CR85","doi-asserted-by":"publisher","first-page":"e13566","DOI":"10.1111\/jsr.13566","volume":"2022","author":"S Bhuniya","year":"2022","unstructured":"Bhuniya, S., Goyal, M., Chowdhury, N. & Mishra, P. Intermittent hypoxia and sleep disruption in obstructive sleep apnea increase serum tau and amyloid-beta levels. J. Sleep Res. 2022, e13566. https:\/\/doi.org\/10.1111\/jsr.13566 (2022).","journal-title":"J. Sleep Res."},{"issue":"5","key":"33701_CR86","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S2213-2600(15)00090-9","volume":"3","author":"I Rosenzweig","year":"2015","unstructured":"Rosenzweig, I. et al. Sleep apnoea and the brain: A complex relationship. Lancet Respir. Med. 3(5), 404\u2013414. https:\/\/doi.org\/10.1016\/S2213-2600(15)00090-9 (2015).","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"33701_CR87","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s11325-020-02033-0","volume":"24","author":"M Tsuyumu","year":"2020","unstructured":"Tsuyumu, M., Tsurumoto, T., Iimura, J., Nakajima, T. & Kojima, H. Ten-year adherence to continuous positive airway pressure treatment in patients with moderate-to-severe obstructive sleep apnea. Sleep Breath. 24(4), 1565\u20131571. https:\/\/doi.org\/10.1007\/s11325-020-02033-0 (2020).","journal-title":"Sleep Breath."},{"key":"33701_CR88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.sleep.2018.07.007","volume":"51","author":"A Palm","year":"2018","unstructured":"Palm, A. et al. Factors influencing adherence to continuous positive airway pressure treatment in obstructive sleep apnea and mortality associated with treatment failure\u2014a national registry-based cohort study. Sleep Med. 51, 85\u201391. https:\/\/doi.org\/10.1016\/j.sleep.2018.07.007 (2018).","journal-title":"Sleep Med."},{"issue":"4","key":"33701_CR89","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/a-1666-5369","volume":"76","author":"J Koehler","year":"2022","unstructured":"Koehler, J. et al. Therapieadh\u00e4renz 3 Monate nach Einleitung einer nichtinvasiven CPAP-Therapie bei 1078 Patienten mit obstruktiver Schlafapnoe (OSA) [adherence to CPAP three months after starting therapy in 1078 Patients with obstructive sleep apnea (OSA)]. Pneumol. (Stuttgart, Germany) 76(4), 251\u2013259. https:\/\/doi.org\/10.1055\/a-1666-5369 (2022).","journal-title":"Pneumol. (Stuttgart, Germany)"},{"issue":"22","key":"33701_CR90","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1182\/blood.V128.22.2444.2444","volume":"128","author":"R Gangaraju","year":"2016","unstructured":"Gangaraju, R., Sundar, K. M., Song, J. & Prchal, J. T. Polycythemia is rarely caused by obstructive sleep apnea. Blood 128(22), 2444. https:\/\/doi.org\/10.1182\/blood.V128.22.2444.2444 (2016).","journal-title":"Blood"},{"issue":"147","key":"33701_CR91","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci. Transl. Med. 4(147), 147. https:\/\/doi.org\/10.1126\/scitranslmed.3003748 (2012).","journal-title":"Sci. Transl. Med."},{"key":"33701_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.conb.2021.07.006","volume":"72","author":"H Benveniste","year":"2022","unstructured":"Benveniste, H. & Nedergaard, M. Cerebral small vessel disease: A glymphopathy?. Curr. Opin. Neurobiol. 72, 15\u201321. https:\/\/doi.org\/10.1016\/j.conb.2021.07.006 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"issue":"6512","key":"33701_CR93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard, M. & Goldman, S. A. Glymphatic failure as a final common pathway to dementia. Science (N. Y.) 370(6512), 50\u201356. https:\/\/doi.org\/10.1126\/science.abb8739 (2020).","journal-title":"Science (N. Y.)"},{"issue":"6156","key":"33701_CR94","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie, L. et al. Sleep drives metabolite clearance from the adult brain. Science (NY, N. Y.) 342(6156), 373\u2013377. https:\/\/doi.org\/10.1126\/science.1241224 (2013).","journal-title":"Science (NY, N. Y.)"},{"issue":"7","key":"33701_CR95","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212(7), 991\u2013999. https:\/\/doi.org\/10.1084\/jem.20142290 (2015).","journal-title":"J. Exp. Med."},{"issue":"7560","key":"33701_CR96","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560), 337\u2013341. https:\/\/doi.org\/10.1038\/nature14432 (2015).","journal-title":"Nature"},{"issue":"32","key":"33701_CR97","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/JNEUROSCI.1974-18.2019","volume":"39","author":"KN Mortensen","year":"2019","unstructured":"Mortensen, K. N. et al. Impaired glymphatic transport in spontaneously hypertensive rats. J. Neurosci. 39(32), 6365\u20136377. https:\/\/doi.org\/10.1523\/JNEUROSCI.1974-18.2019 (2019).","journal-title":"J. Neurosci."},{"issue":"3","key":"33701_CR98","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/brain\/awac076","volume":"146","author":"EE Beaman","year":"2023","unstructured":"Beaman, E. E. et al. Blood-brain barrier permeable \u03b2-blockers linked to lower risk of Alzheimer\u2019s disease in hypertension. Brain 146(3), 1141\u20131151. https:\/\/doi.org\/10.1093\/brain\/awac076 (2023).","journal-title":"Brain"},{"issue":"48","key":"33701_CR99","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1093\/eurheartj\/ehac584","volume":"43","author":"R Peters","year":"2022","unstructured":"Peters, R. et al. Blood pressure lowering and prevention of dementia: An individual patient data meta-analysis. Eur. Heart J. 43(48), 4980\u20134990. https:\/\/doi.org\/10.1093\/eurheartj\/ehac584 (2022).","journal-title":"Eur. Heart J."},{"issue":"17","key":"33701_CR100","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1073\/pnas.1721694115","volume":"115","author":"E Shokri-Kojori","year":"2018","unstructured":"Shokri-Kojori, E. et al. \u03b2-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc. Natl. Acad. Sci. 115(17), 4483\u20134488. https:\/\/doi.org\/10.1073\/pnas.1721694115 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"33701_CR101","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/brain\/awaa443","volume":"144","author":"PK Eide","year":"2021","unstructured":"Eide, P. K., Vinje, V., Pripp, A. H., Mardal, K.-A. & Ringstad, G. Sleep deprivation impairs molecular clearance from the human brain. Brain 144(3), 863\u2013874. https:\/\/doi.org\/10.1093\/brain\/awaa443 (2021).","journal-title":"Brain"},{"issue":"1","key":"33701_CR102","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3174\/ajnr.A7334","volume":"43","author":"J Kikuta","year":"2022","unstructured":"Kikuta, J. et al. An investigation of water diffusivity changes along the perivascular space in elderly subjects with hypertension. AJNR Am. J. Neuroradiol. 43(1), 48\u201355. https:\/\/doi.org\/10.3174\/ajnr.A7334 (2022).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"33701_CR103","doi-asserted-by":"publisher","first-page":"884234","DOI":"10.3389\/fnins.2022.884234","volume":"16","author":"B Roy","year":"2022","unstructured":"Roy, B. et al. Impaired glymphatic system actions in obstructive sleep apnea adults. Front. Neurosci. 16, 884234. https:\/\/doi.org\/10.3389\/fnins.2022.884234 (2022).","journal-title":"Front. Neurosci."},{"issue":"4","key":"33701_CR104","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s00415-022-11530-z","volume":"270","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Impaired glymphatic drainage underlying obstructive sleep apnea is associated with cognitive dysfunction. J. Neurol. 270(4), 2204\u20132216. https:\/\/doi.org\/10.1007\/s00415-022-11530-z (2023).","journal-title":"J. Neurol."},{"issue":"1","key":"33701_CR105","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola, C. The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease. Neuron 96(1), 17\u201342. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.030 (2017).","journal-title":"Neuron"},{"issue":"7","key":"33701_CR106","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","volume":"15","author":"V Hachinski","year":"2019","unstructured":"Hachinski, V. et al. Preventing dementia by preventing stroke: The Berlin Manifesto. Alzheimer. Dementia J. Alzheim. Assoc. 15(7), 961\u2013984. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.001 (2019).","journal-title":"Alzheimer. Dementia J. Alzheim. Assoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33701-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33701-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33701-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:05:42Z","timestamp":1683702342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33701-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33701"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33701-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7556"}}